Actinium Pharmaceuticals reported $9.26M in Current Liabilities for its fiscal quarter ending in June of 2026.





Current Liabilities Change Date
AbbVie USD 41.64B 458M Jun/2026
Actinium Pharmaceuticals USD 9.26M 1.91M Jun/2026
Amgen USD 25.5B 547M Jun/2026
Bioline Rx USD 13.62M 1.5M Mar/2026
Capricor Therapeutics USD 32.96M 676K Jun/2026
Pfizer USD 32.65B 1.7B Jun/2026